阿奇霉素治療小兒肺炎支原體感染合并咳嗽變異性哮喘的臨床療效觀察

打開文本圖片集

【摘 要】目的：在進行肺炎支原體感染合并咳嗽性哮喘小兒疾病治療時，應用阿奇霉素治療療效。方法：選擇2019年1月至2020年1月本院診治的80例肺炎支原體感染患者，全部患者合并咳嗽性哮喘。分別納入康復組（總共40例）與對比組（總共40例）?？祻徒M和對比組各自應用阿奇霉素與紅霉素腸溶膠囊醫(yī)治。結(jié)果：醫(yī)治后，康復組的醫(yī)治成功率為95.0%，復發(fā)性為7.5%，對比組的醫(yī)治成功率為77.5%，復發(fā)性為25.0%，差別存有明顯的統(tǒng)計學意義（P

【關(guān)鍵詞】紅霉素腸溶膠囊；阿奇霉素；肺炎支原體；肺炎；咳嗽性哮喘

Clinical observation of azithromycin in the treatment of Mycoplasma pneumoniae infection complicated with cough variant asthma in children

HOU Baoyu

Department of Pediatrics， Dongming people’s Hospital， Heze Shandong 274500， China

【Abstract】Objective： To study the efficacy of using azithromycin in the diagnosis and treatment of children with Mycoplasma pneumoniae infection combined with cough variant asthma. Methods： Selecting 80 patients with Mycoplasma pneumoniae infection diagnosed and treated in our hospital from January 2019 to January 2020， all patients were complicated with cough variant asthma. They were included in the rehabilitation group （40 cases in total） and the control group（40 cases in total）.The rehabilitation group and the control group were treated with azithromycin and erythromycin enteric-coated capsules respectively. Results： After treatment， the treatment success rate of the rehabilitation group was 95.0%， and the recurrence rate was 7.5% in the rehabilitation group， and the treatment success rate of the control group was 77.5%， and the recurrence rate was 25.0% in the control group. The differences were statistically significant（P

【Key？Words】Erythromycin enteric-coated capsules； Azithromycin；Mycoplasma pneumonia； Pneumonia； Cough variant asthma

在臨床醫(yī)學上，支氣管哮喘屬于呼吸類的疾病，患病率非常高，這種病癥往往存在獨特的類型便是變異性哮喘，發(fā)病原因往往是由于肺部的支原體感染造成[1]。（剩余3042字）